Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Amivantamab for Esophageal Cancer
Recruiting1 awardPhase 2
Middletown, New Jersey
This trial is testing a drug called amivantamab to see if it can treat esophagogastric cancer with specific genetic changes. The drug works by blocking proteins that help cancer cells grow. Researchers also want to know if the drug is safe and causes only mild side effects.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service